Triheptanoin | Interleukin Related interleukin-related.com

Product Name :
Triheptanoin

Search keywords :
Triheptanoin

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Fatty acid replacements

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Baylor Research Institute Llc

Active Company_Name :
Baylor Research Institute Llc

Active Indication_Name:
Lipid Metabolism Disorders

In Active Indication_Name:
Polyglucosan Body Disease, Adult Form

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MCL1 Antibody
MMP9 Antibody
PKC delta Antibody: PKC delta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC delta. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts